Patents by Inventor Michael Snabes

Michael Snabes has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS FOR TREATING FEMALE SEXUAL DYSFUNCTION WHILE DECREASING CARDIOVASCULAR RISK
    Publication number: 20170128462
    Abstract: Methods for treating female sexual dysfunction are provided. In particular, methods for treating a woman having HSDD by administering to the woman a therapeutically effective amount of an androgen, whereby the therapeutically effective amount of the androgen is administered in a manner that results in a reduction in expected number of cardiovascular events in the woman are provided.
    Type: Application
    Filed: October 21, 2016
    Publication date: May 11, 2017
    Inventors: Stephen SIMES, Michael SNABES, Joanne ZBOROWSKI
  • Methods for decreasing cardiovascular risk in postmenopausal women
    Publication number: 20120022033
    Abstract: Methods for decreasing the risk of cardiovascular events in postmenopausal women having a high risk for a cardiovascular event are provided. In particular, methods for decreasing the risk of cardiovascular events in postmenopausal woman at high risk for cardiovascular events by administering to the woman a therapeutically effective amount of an androgen, whereby administering the androgen decreases the risk of cardiovascular events in the woman compared to untreated postmenopausal woman at high risk for cardiovascular events are provided.
    Type: Application
    Filed: July 20, 2011
    Publication date: January 26, 2012
    Applicant: BIOSANTE PHARMACEUTICALS, INC.
    Inventors: Stephen Simes, Michael Snabes, Joanne Zborowski
  • Methods for treating sexual dysfunction while decreasing cardiovascular risk
    Publication number: 20120004204
    Abstract: Methods for treating female sexual dysfunction are provided. In particular, methods for treating a woman having HSDD by administering to the woman a therapeutically effective amount of an androgen, whereby the therapeutically effective amount of the androgen is administered in a manner that results in a reduction in expected number of cardiovascular events in the woman are provided.
    Type: Application
    Filed: June 29, 2011
    Publication date: January 5, 2012
    Applicant: BIOSANTE PHARMACEUTICALS, INC.
    Inventors: Stephen Simes, Michael Snabes, Joanne Zborowski